Patent · US Active

Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)

US9453074B2 · kind B2 · utility

30Cited by
19References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 16, 2014
Grant dateSep 27, 2016
Priority date—
Expiry dateMay 12, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/16134
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention includes compositions and methods for making and using anti DC-ASGPR antibodies that can, e.g., activate DCs and other cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.